Net profit of Concord Biotech rose 10.62% to Rs 54.49 crore in the quarter ended June 2023 as against Rs 49.26 crore during the previous quarter ended June 2022. Sales rose 7.64% to Rs 194.83 crore in the quarter ended June 2023 as against Rs 181.00 crore during the previous quarter ended June 2022.
Powered by Capital Market - Live News